| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | Healthcare | Erste Group | Upgrade | Hold → Buy | — | $432.4B | $243.80 | +1.3% | +1.0% | -0.9% | +0.9% | +0.8% | — |
| AMAT | Technology | Erste Group | Downgrade | Buy → Hold | — | $430.8B | $546.62 | -0.4% | -2.3% | -1.3% | +2.2% | -3.2% | — |
| CVX | Energy | TD Cowen | Reiterates | Hold | $205 | $379.2B | $190.40 | +0.4% | -2.1% | +1.5% | -1.4% | +4.5% | — |
| AMGN | Healthcare | Truist | Reiterates | Hold | $362 | $210.5B | $390.02 | +0.9% | +4.6% | -0.7% | +1.5% | +1.5% | — |
| AMGN | Healthcare | Oppenheimer | Reiterates | Outperform | $450 | $210.5B | $390.02 | +0.9% | +4.6% | -0.7% | +1.5% | +1.5% | — |
| AMGN | Healthcare | Morgan Stanley | Reiterates | Equal-Weight | $351 | $210.5B | $390.02 | +0.9% | +4.6% | -0.7% | +1.5% | +1.5% | — |
| AMGN | Healthcare | RBC Capital Mkts | Reiterates | Outperform | $400 | $210.5B | $390.02 | +0.9% | +4.6% | -0.7% | +1.5% | +1.5% | — |
| AMGN | Healthcare | Robert W. Baird | Reiterates | Underperform | $230 | $210.5B | $390.02 | +0.9% | +4.6% | -0.7% | +1.5% | +1.5% | — |
| AMGN | Healthcare | BofA Securities | Reiterates | Underperform | $317 | $210.5B | $390.02 | +0.9% | +4.6% | -0.7% | +1.5% | +1.5% | — |
| AMGN | Healthcare | Canaccord Genuity | Reiterates | Hold | $384 | $210.5B | $390.02 | +0.9% | +4.6% | -0.7% | +1.5% | +1.5% | — |
| AMGN | Healthcare | Wells Fargo | Reiterates | Equal Weight | $400 | $210.5B | $390.02 | +0.9% | +4.6% | -0.7% | +1.5% | +1.5% | — |
| AMGN | Healthcare | BMO Capital Markets | Reiterates | Outperform | $450 | $210.5B | $390.02 | +0.9% | +4.6% | -0.7% | +1.5% | +1.5% | — |
| MCD | Consumer Cyclical | KeyBanc Capital Markets | Reiterates | Overweight | $305 | $190.7B | $268.34 | +1.2% | +2.1% | +0.8% | -0.6% | -0.3% | — |
| MCD | Consumer Cyclical | Deutsche Bank | Reiterates | Buy | $345 | $190.7B | $268.34 | +1.2% | +2.1% | +0.8% | -0.6% | -0.3% | — |
| MCD | Consumer Cyclical | Robert W. Baird | Reiterates | Neutral | $285 | $190.7B | $268.34 | +1.2% | +2.1% | +0.8% | -0.6% | -0.3% | — |
| MCD | Consumer Cyclical | RBC Capital Mkts | Reiterates | Sector Perform | $295 | $190.7B | $268.34 | +1.2% | +2.1% | +0.8% | -0.6% | -0.3% | — |
| MCD | Consumer Cyclical | Morgan Stanley | Reiterates | Equal-Weight | $319 | $190.7B | $268.34 | +1.2% | +2.1% | +0.8% | -0.6% | -0.3% | — |
| CRM | Technology | Erste Group | Upgrade | Hold → Buy | — | $157.6B | $190.99 | +1.2% | +1.0% | -3.2% | +3.2% | +2.5% | — |
| BMY | Healthcare | ArgusD | Upgrade | Hold → Buy | $75 | $134.6B | $65.89 | -1.6% | -3.4% | +0.8% | +0.9% | +0.2% | — |
| PLD | Real Estate | RBC Capital Mkts | Upgrade | Sector Perform → Outperform | $160 | $129.7B | $139.05 | +0.5% | +1.2% | -1.2% | +0.7% | -1.0% | — |